NCT00733148

Brief Summary

The EU funded project CLINICIP (Closed Loop Insulin Infusion for Critically Ill Patients) aims to develop a low-risk monitoring and control device which allows maintaining metabolic control in intensive care units. A system will be developed comprising three subsystems: a body interface for the delivery of biofluids, biosensors for the determination of glucose concentration in these biofluids and an adaptive control algorithm that generates advice and thus represents a decision support system with respect to insulin infusion rate to establish glycaemic control in critically ill patients. Within a closed loop system, intensified insulin treatment will make use of the calculations leading to external regulation of glucose. It is the aim of this study to evaluate the correlation between arterial blood glucose concentrations and interstitial fluid glucose concentrations in post surgery patients in the Intensive Care Unit (ICU). Interstitial fluid glucose concentrations are based on microdialysis in subcutaneous adipose tissue and calculated using the ionic reference technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2004

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2005

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2005

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

August 7, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2008

Completed
Last Updated

August 12, 2008

Status Verified

August 1, 2008

Enrollment Period

6 months

First QC Date

August 7, 2008

Last Update Submit

August 7, 2008

Conditions

Keywords

glucose, interstitial, intensive care

Outcome Measures

Primary Outcomes (1)

  • Time concentration profiles of arterial blood glucose concentrations and interstitial fluid glucose concentrations

    hourly

Secondary Outcomes (1)

  • Prospectively calibrated interstitial fluid glucose concentration profiles

    hourly

Study Arms (2)

1

Routine Care

Drug: dosing of insulin

2

Insulin infusion based on model predictive algorithm (MPC)

Drug: dosing of insulin

Interventions

Dosing od insulin is calculated by a computer based algorithm

Also known as: Model predictive control
12

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a blood glucose level of more than 120 mg/dl (6.7mM) at admission to the ICU after surgery

You may qualify if:

  • Signed informed consent obtained before any trial-related activities.
  • Planned surgery and post-surgery stay in the ICU.
  • Age of patients in the range from 18 to 90 years.

You may not qualify if:

  • Known or suspected allergy against insulins.
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation.
  • Any disease or condition which the Investigator or the treating physician feels would interfere with the trial or the safety of the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Graz

Graz, Styria, A8036, Austria

Location

Related Publications (1)

  • Schaupp L, Plank J, Kohler G, Schaller R, Wrighton C, Ellmerer M, Pieber TR. Prediction of glucose concentration in post-cardiothoracic surgery patients using continuous glucose monitoring. Diabetes Technol Ther. 2011 Feb;13(2):127-34. doi: 10.1089/dia.2010.0117.

Study Officials

  • Thomas R. Pieber, MD

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 7, 2008

First Posted

August 12, 2008

Study Start

July 1, 2004

Primary Completion

January 1, 2005

Study Completion

April 1, 2005

Last Updated

August 12, 2008

Record last verified: 2008-08

Locations